MTIP is proud to announce the successful acquisition of its portfolio company Cynerio by Axonius, one of the world’s fastest-growing cybersecurity companies.
MTIP is proud to announce the successful acquisition of its portfolio company Cynerio by Axonius, one of the world’s fastest-growing cybersecurity companies, currently valued at $2.6 billion.
This strategic acquisition marks the culmination of Cynerio’s mission to protect healthcare environments from cyber threats. As the leader for modern healthcare cybersecurity, Cynerio developed a powerful platform that safeguards the connected clinical ecosystem – delivering visibility, risk mitigation, and real-time protection to healthcare institutions worldwide. These capabilities will now strengthen and expand Axonius’ offering for the healthcare sector.
“Since our initial investment in Cynerio, we’ve believed in their transformative vision and world-class team,” said Dr. Christoph Kausch, Managing Partner at MTIP. “This acquisition by Axonius validates Cynerio’s unique position in the cybersecurity landscape and further underscores the importance of securing the rapidly expanding universe of connected medical devices in hospitals.”
Healthcare organizations are facing an unprecedented challenge: A proliferation of connected medical devices that traditional security tools struggle to monitor and protect. By joining forces, Axonius and Cynerio are addressing this critical issue head-on. As Dean Sysman, Co-Founder and CEO of Axonius, stated: “By integrating Cynerio’s capabilities into Axonius, we’ll create the industry’s first unified view across all connected assets—from cloud workloads to cardiac monitors.”
Cynerio’s technology and expertise will now enhance Axonius’ ability to meet the unique cybersecurity needs of healthcare organizations—strengthening its position as a leader in asset intelligence and protection. The transaction is backed by leading Axonius investors, including Lightspeed Venture Partners, Bessemer Venture Partners, and Accel, underscoring strong support for the company’s expansion into healthcare cybersecurity.
At MTIP, we are proud to have supported Cynerio on its journey from early growth to a successful strategic exit. This achievement reflects our ongoing commitment to investing in category-defining healthcare software companies that drive both clinical impact and commercial success.
About Axonius:
Axonius transforms asset intelligence into intelligent action. With the Axonius Asset Cloud, customers preemptively tackle high-risk and hard-to-spot threat exposures, misconfigurations, and overspending. The integrated platform brings together data from every system in an organization’s IT infrastructure to optimize mission-critical risk, performance, and cost measures via actionable intelligence. Covering cyber assets, software, SaaS applications, identities, vulnerabilities, infrastructure, and more, Axonius is the one place to go for Security, IT, and GRC teams to continuously drive actionability across the organization. Cited as one of the fastest-growing cybersecurity startups, with accolades from CNBC, Forbes, and Fortune, Axonius supports millions of assets for leading customers across industries and around the world. Learn more at www.axonius.com.
About Cynerio:
Cynerio has one simple goal—to secure every medical device in healthcare environments. With capabilities ranging from microsegmentation and improved device insight to identifying exposed ePHI and stopping ransomware, Cynerio provides the technology and expertise needed to protect hospitals from a variety of cyberattacks.
About MTIP:
MTIP is a leading Swiss-based growth equity and buyout firm specializing in investments in European healthcare software companies. Our strategy focuses on partnering with high-growth, profitable businesses and visionary management teams. Leveraging our deep sector expertise, we help scale successful healthcare software companies achieve their full potential. At MTIP, our purpose is clear: Unlocking value, improving lives. Together with our portfolio companies, we create sustainable growth, advance innovation, and deliver long-term value that reshapes the global healthcare landscape. For more information, visit www.mtip.ch.
Media Contact:
Anja-Vanessa Peter
Investor Relations & Communication Manager